Approach to the Neonate with Thrombocytopenia and Hemorrhage in the Pediatric Emergency Department

cocukacil-5-1-2024

Emel ÖZYÜREKa

aHealth Sciences University Ankara Training and Research Hospital, Clinic of Pediatric Hematology and Oncology, Ankara, Türkiye

ABSTRACT
Bleeding in a newborn is often a serious health problem, deteriorating the general condition of the baby in a short time. It is commonly seen in the neonatal intensive care units as well as in the pediatric emergency services. The most common bleeding disorder in the newborns is thrombocytopenia, but other coagulopathies can also occur. The etiology of the bleeding in newborns mostly related to underlying maternal or neonatal diseases. To interpret coagulation laboratory results of newborns, developmental hemostasis should be well known. The treatment is given according to underlying condition causing bleeding in the newborn.
Keywords: Bleeding disorder; nenotates/newborns; coagulopathy; thrombocytopenia

Referanslar

  1. Venkatesh V, Curley A, Khan R, Clarke P, Watts T, Josephson C, et al. A novel approach to standardised recording of bleeding in a high risk neonatal population. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F260-3. [Crossref]  [PubMed]
  2. Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F475-8. [Crossref]  [PubMed]  [PMC]
  3. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165-72. [Crossref]  [PubMed]
  4. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood. 1988;72(5):1651-7. [Crossref]  [PubMed]
  5. Revel-Vilk S. The conundrum of neonatal coagulopathy. Hematology Am Soc Hematol Educ Program. 2012;2012:450-4. [Crossref]  [PubMed]
  6. Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95(2):362-72. [Crossref]  [PubMed]
  7. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol. 2009;29(2):130-6. [Crossref]  [PubMed]
  8. Israels SJ, Cheang T, Roberston C, McMillan-Ward EM, McNicol A. Impaired signal transduction in neonatal platelets. Pediatr Res. 1999;45(5 Pt 1):687-91. [Crossref]  [PubMed]
  9. Bednarek FJ, Bean S, Barnard MR, Frelinger AL, Michelson AD. The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res. 2009;124(1):42-5. [Crossref]  [PubMed]
  10. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992;80(8):1998-2005. [Crossref]  [PubMed]
  11. Williams MD, Chalmers EA, Gibson BE; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119(2):295-309. [Crossref]  [PubMed]
  12. Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia. 2010 Jul;16 Suppl 5:168-75. [Crossref]  [PubMed]
  13. Jaffray J, Young G, Ko RH. The bleeding newborn: A review of presentation, diagnosis, and management. Semin Fetal Neonatal Med. 2016;21(1):44-9. [Crossref]  [PubMed]
  14. Davenport P, Sola-Visner M. Hemostatic Challenges in Neonates. Front Pediatr. 2021;9:627715. [Crossref]  [PubMed]  [PMC]
  15. Ignjatovic V, Kenet G, Monagle P; Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting pediatric samples. J Thromb Haemost. 2012;10(2):298-300. [Crossref]  [PubMed]
  16. McMillan D, Wu J. Approach to the bleeding newborn. Paediatr Child Health. 1998;3(6):399-401. [Crossref]  [PubMed]  [PMC]
  17. Poryo M, Boeckh JC, Gortner L, Zemlin M, Duppré P, Ebrahimi-Fakhari D, et al; PROGRESS study consortium and NGFN - Nationales Genomforschungsnetz Deutschland. Ante-, peri- and postnatal factors associated with intraventricular hemorrhage in very premature infants. Early Hum Dev. 2018;116:1-8. [Crossref]  [PubMed]
  18. Antmen B, Şaşmaz İ, Karagün BŞ. Yenidoğanda kanama diyatezine yaklaşım. Türk Hematolji Derneği, TPHD Eğitim Serisi-III. 2016;1(3):623-31.
  19. Timur AA, Gürgey A, Aktuglu G, Kavakli K, Canatan D, Olek K, et al. Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations. Haemophilia. 2001;7(5):475-81. [Crossref]  [PubMed]
  20. Manukjan G, Bösing H, Schmugge M, Straub G, Schulze H. Impact of genetic variants on haematopoesis in patients with thrombocytopenia absent radii (TAR) syndrome. Br J Haematol. 2017;179:606-17. [Crossref]  [PubMed]
  21. Khincha PP, Savage SA. Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonat Med. 2016;57-65. [Crossref]  [PubMed]  [PMC]
  22. Swerdin A, Berkowitz C, Craft N. Cutaneous signs of child abuse. J Am Acad Dermatol. 2007;57:371-92. [Crossref]  [PubMed]
  23. Stirling J Jr; American Academy of Pediatrics Committee on Child Abuse and Neglect. Beyond Munchausen syndrome by proxy: identification and treatment of child abuse in a medical setting. Pediatrics. 2007;119(5):1026-30. [Crossref]  [PubMed]
  24. Ozsoylu S. Pseudothrombocytopenia in a neonate due to mother. Eur J Pediatr. 2014;173(4):553. [Crossref]  [PubMed]
  25. Del Vecchio A, Latini G, Henry E, Christensen RD. Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol. 2008; 28(6):427-31. [Crossref]  [PubMed]
  26. Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16(6):301-4. [Crossref]  [PubMed]
  27. Chakravorty S, Roberts I. How I manage neonatal thrombocytopenia. Br JHaematol. 2012;156:155-62. [Crossref]  [PubMed]
  28. Carr R, Kelly AM, Williamson LM. Neonatal thrombocytopenia and platelet transfusion-a UK perspective. Neonatology. 2014;107:1-7. [Crossref]  [PubMed]
  29. Van der Lugt NM, Van Kampen A, Walther FJ, Brand A, Lopriore E. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. Vox Sanguinis. 2013;105:236-43. [Crossref]  [PubMed]
  30. Shirahata A, Itou S, Takahashi Y, Nishiguchi T, Mastuda Y. Modified guideline of vitamin K administration for vitamin K deficiency in infancy. J Jpn Pediatric Soc. 2011;115:705-12.
  31. Flood VH, Galderisi FC, Lowas SR, Kendrick A, Boshkov LK. Hemorrhagic disease of the newborn despite vitamin K prophylaxis at birth. Pediatr Blood Cancer. 2008;50:1075-7. [Crossref]  [PubMed]
  32. Araki S, Shirahata A. Vitamin K deficiency bleeding in infancy. Nutrients. 2020;12:780. [Crossref]  [PubMed]  [PMC]
  33. Veldman A, Fischer D, Nold MF, Wong FY. Disseminated intravascular coagulation in term and preterm neonates. Semin Fetal Neonat Med. 2010;36:419-28. [Crossref]  [PubMed]
  34. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management-state of the art. Europ JPediatr. 2011;170:573-81. [Crossref]  [PubMed]
  35. Yao SL, Smit E, Odd D. The Effectiveness of interventions to prevent intraventricular haemorrhage in premature infants: A systematic review and network meta-analysis. Journal of neonatal-perinatal medicine. J Neonat Perinat Med. 2023;16:5-20. [Crossref]  [PubMed]
  36. McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35:777-92. [Crossref]  [PubMed]  [PMC]